Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium.
about
Kidney xenotransplantationClinical lung xenotransplantation--what donor genetic modifications may be necessary?Immune modulation in xenotransplantationCoagulation dysregulation as a barrier to xenotransplantation in the primateControlling coagulation dysregulation in xenotransplantation.Overcoming the barriers to xenotransplantation: prospects for the futureCurrent status of xenotransplantation and prospects for clinical applicationCurrent status of animal-to-human transplantation.Glucose metabolism in pigs expressing human genes under an insulin promoter.Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.Xenotransplantation literature update November-December, 2004.Endothelial cell protection in xenotransplantation: looking after a key player in rejection.Coagulation and the xenograft endothelium.Gal knockout and beyond.The interface between coagulation and immunity.Recombinant pig TFPI efficiently regulates human tissue factor pathwaysWhich anti-platelet therapies might be beneficial in xenotransplantation?Frankenswine, or bringing home the bacon: How close are we to clinical trials in xenotransplantation?Xenotransplantation as a model of integrated, multidisciplinary researchDNA microarray-based gene expression profiling in porcine keratocytes and corneal endothelial cells and comparative analysis associated with xeno-related rejection.Xenotransplantation: the next generation of engineered animalsUpdate: cardiac xenotransplantation.Complement activation and coagulation in xenotransplantation.Antibody-mediated xenograft injury: mechanisms and protective strategies.Transplant accommodation--are the lessons learned from xenotransplantation pertinent for clinical allotransplantation?The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.Spatiotemporal control of porcine p65RHD expression by advanced Tet-On system in PIEC cells helps regulate NFкB activity.Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition.Protease-activated receptor 1 activation is necessary for monocyte chemoattractant protein 1-dependent leukocyte recruitment in vivo.Anti-inflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice.Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells.Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation.Recent advances in pig-to-human organ and cell transplantation.Thrombalexins: Cell-Localized Inhibition of Thrombin and Its Effects in a Model of High-Risk Renal Transplantation.Fibrocytes mediate intimal hyperplasia post-vascular injury and are regulated by two tissue factor-dependent mechanisms
P2860
Q26822638-89267987-5013-4C81-9E3A-D67EF9D971ADQ26823663-3AE12E66-5B2D-42C6-819A-CF4A33EE368AQ26826905-92CA18C7-BB6D-4399-8D1B-E50FEF6557B5Q33381973-BFDA5D06-7F8E-4CF9-971B-FCCFAA102B55Q33394542-492CF7D0-DCC7-4803-8B42-3F0B34F1BC1EQ33801035-EE320013-206D-4B80-B479-EBF3E7D6C655Q33835678-62F0C3B7-8F70-4C7A-B071-861002602971Q34665240-C22A6CB3-D4A1-457D-8097-AE7E90399FE2Q35085119-A2319FC5-AD82-4EEA-AA20-B68EE46DA87DQ35940563-A455DCCD-DBFD-4D9B-B33B-57BF9882EFBEQ36031623-6C2E46AC-6734-434A-9673-E1CC48175C9BQ36404498-51E648B5-341D-4BA8-9749-6DC5421D8590Q36703877-8C239081-03C1-4BEA-A92B-5568DB7D4D31Q36709669-23C55C77-3FCB-4913-8A75-4ED088E792C9Q36710224-77038176-3935-44CB-BDB5-CC5716EC6EF6Q36840183-A6A70813-9E76-464C-9915-D1982D7541BAQ37069089-3840947E-36F0-428C-98CF-30396C7538A1Q37080101-715B45B4-A6F6-4F2F-B03A-C9B9F5FF146FQ37137178-3D13BD0E-5EF6-4FAF-9550-08B45DC88417Q37166545-4937CD05-E03E-4419-B035-4BD27C288447Q37313536-92930913-59A1-4490-9FEF-6CD43CD0EE37Q37342534-D3C11D51-3916-4D94-B5DA-B423C5F3DD93Q37372498-A54E947D-8B6C-43CF-9263-EA41F6B5F083Q37450148-49B4B5F7-E0FB-47D8-8603-9E9A58264AA2Q37952349-2240B534-C271-438B-B533-94BAC7805A52Q38191251-B5BD0F3F-84B2-4551-980F-A55829DC0942Q39032896-5FB56D31-5395-4E87-8B11-0A656BA584FAQ39246204-BB639800-2222-4CEF-81BF-044ADDF332D2Q41835663-D2E6FAFA-A188-4432-93D8-35AC6F07D894Q42069374-F1CF4878-A827-4136-8CD7-8D89E89307D4Q42395227-104A673F-1546-4D93-9F25-B1140E53ED36Q43185385-DAA7C9C3-0D46-4573-B5BB-B56CF00F5363Q43414006-8F6F68C5-AABA-4290-B9F3-5D0B4A50D17FQ46849311-82D1213B-F59F-44FF-96ED-811F788E8B82Q51664794-0B591080-25D2-48C8-B197-B6269CCD7F30Q58836878-76381D32-193E-4E9F-86C4-AAA2A014596A
P2860
Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Complete inhibition of acute h ...... ants on xenograft endothelium.
@en
Complete inhibition of acute h ...... ants on xenograft endothelium.
@nl
type
label
Complete inhibition of acute h ...... ants on xenograft endothelium.
@en
Complete inhibition of acute h ...... ants on xenograft endothelium.
@nl
prefLabel
Complete inhibition of acute h ...... ants on xenograft endothelium.
@en
Complete inhibition of acute h ...... ants on xenograft endothelium.
@nl
P2093
P2860
P50
P921
P1476
Complete inhibition of acute h ...... lants on xenograft endothelium
@en
P2093
Daxin Chen
Edward G D Tuddenham
Geoffrey Kemball-Cook
Robert I Lechler
P2860
P304
P356
10.1111/J.1600-6143.2004.00625.X
P407
P577
2004-12-01T00:00:00Z